BDBM286144 4-(4-(3-(5- methyl-1,2,4- oxadiazol-3-yl) benzyloxy) bicyclo[2.2.1] heptan-1-yl) butanoic acid::US9518000, Example 37
SMILES: Cc1nc(no1)-c1cccc(COC23CCC(CCCC(O)=O)(CC2)C3)c1
InChI Key: InChIKey=OBXSHSNMGZNJNN-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free fatty acid receptor 4 (Homo sapiens (Human)) | BDBM286144 (4-(4-(3-(5- methyl-1,2,4- oxadiazol-3-yl) benzylox...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.12E+3 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for... | US Patent US9518000 (2016) BindingDB Entry DOI: 10.7270/Q2GH9M00 | |||||||||||
More data for this Ligand-Target Pair |